Skip to main content

Apellis Pharmaceuticals, Inc.

APLSDelisted May 14, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001492422

Apellis Pharmaceuticals, Inc. was delisted on May 14, 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Apellis Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Apellis Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Apellis Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Wheeler Craig ADirector0May 14, 20262
Dolsten MikaelDirector0May 14, 20262
Machiels AlecDirector0May 14, 20262
Chan GeraldDirector0May 14, 20262
Watson David O.General Counsel0May 14, 20269
Deschatelets PascalChief Scientific Officer0May 14, 20265
Francois CedricChief Executive Officer0May 14, 20267
Sullivan Timothy EugeneChief Financial Officer0May 14, 20267
O'Brien Stephanie MonaghanDirector0May 14, 20263
Dunlop A. SinclairDirector0May 14, 20264
Fonteyne Paul R.Director0May 14, 20262
Nicholson NurChief Technical Officer0May 14, 20265
Chopas James GeorgeVP/Chief Accounting Officer0May 14, 20265
DeLong Mark JeffreyChief Business & Strat Officer0May 14, 20266
Baumal CarolineChief Medical Officer0May 14, 20265
Walbert KeliDirector0May 14, 20262
Boucher KelleyChief People Officer0May 14, 20262
Meltzer LeslieChief Research and Development0May 14, 20262
Townsend Adam J.Chief Commercial Officer84,050Jan 30, 20250
Lewis KarenChief People Officer70,251Jan 30, 20250
Eisele JeffreyChief Development Officer55,312Jan 30, 20250
Scheibler LukasChief Research Officer68,299Dec 5, 20230
Brown Victoria L.Program Team Lead23,556Jan 24, 20230
Grossi FedericoChief Medical Officer94,884Jan 9, 20230
Morningside Venture Investments Ltd10% Owner12,806,342Nov 18, 20210
Perry Nicole DVice President - Accounting4,847Aug 3, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 21, 2023 (view filing)Nov 21Same dayFrancois CedricChief Executive OfficerSSale−5.00K$48.80−$244.0K−1.8%269.7K after
Nov 21, 2023 (view filing)Oct 1735 daysLateDunlop A. SinclairDirectorSSale−24.0K$49.00−$1.18M−10.0%216.7K after
Nov 20, 2023 (view filing)Nov 173 daysMachiels AlecDirectorSSale−1.25K$47.74−$59.7K−0.3%367.4K after10b5-1
Nov 9, 2023 (view filing)Nov 81 dayDeschatelets PascalChief Scientific OfficerSSale−12.0K$47.27−$567.2K−1.1%1.07M after10b5-1
Oct 24, 2023 (view filing)Oct 231 dayChopas James GeorgeVP/Chief Accounting OfficerSSale−132$46.04−$6.08K−0.4%32.7K after
Oct 24, 2023 (view filing)Oct 231 dayDeLong Mark JeffreyChief Business & Strat OfficerSSale−131$46.04−$6.03K−0.3%51.6K after
Oct 18, 2023 (view filing)Oct 171 dayMachiels AlecDirectorSSale−1.25K$48.50−$60.6K−0.3%367.4K after10b5-1
Oct 10, 2023 (view filing)Oct 91 dayDeschatelets PascalChief Scientific OfficerSSale−12.0K$40.38−$484.6K−1.1%1.07M after10b5-1
Sep 19, 2023 (view filing)Sep 181 dayMachiels AlecDirectorSSale−1.25K$45.00−$56.3K−0.3%367.4K after10b5-1
Sep 19, 2023 (view filing)Sep 181 dayNicholson NurChief Technical OfficerSSale−20.4K$44.27−$900.9K−27.6%53.3K after2 lots
Sep 18, 2023 (view filing)Sep 153 daysMachiels AlecDirectorSSale−1.25K$45.34−$56.7K−0.3%367.4K after10b5-1
Sep 11, 2023 (view filing)Sep 83 daysDeschatelets PascalChief Scientific OfficerSSale−12.0K$42.87−$514.4K−1.1%1.06M after10b5-1
Sep 7, 2023 (view filing)Sep 61 dayScheibler LukasChief Research OfficerSSale−1.76K$43.01−$75.5K−2.5%68.3K after
Sep 1, 2023 (view filing)Aug 311 dayChopas James GeorgeVP/Chief Accounting OfficerSSale−551$41.23−$22.7K−1.8%30.3K after
Sep 1, 2023 (view filing)Sep 1Same dayFrancois CedricChief Executive OfficerSSale−150.0K$41.75−$6.26M−26.1%424.7K after2 lots
Aug 9, 2023 (view filing)Aug 81 dayDeschatelets PascalChief Scientific OfficerSSale−12.0K$23.66−$283.9K−1.1%1.05M after10b5-1
Jul 18, 2023 (view filing)Jul 171 dayMachiels AlecDirectorSSale−1.25K$64.79−$81.0K−0.5%267.6K after10b5-1
Jul 11, 2023 (view filing)Jul 101 dayDeschatelets PascalChief Scientific OfficerSSale−12.0K$84.55−$1.01M−1.1%1.05M after10b5-1
Jul 6, 2023 (view filing)Jul 33 daysWatson David O.General CounselSSale−8.51K$89.98−$765.7K−9.0%85.8K after10b5-1
Jul 6, 2023 (view filing)Jul 33 daysSullivan Timothy EugeneChief Financial OfficerSSale−6.78K$89.97−$609.9K−8.0%77.7K after3 lots10b5-1
Jun 21, 2023 (view filing)Jun 201 dayMachiels AlecDirectorSSale−1.25K$88.41−$110.5K−0.5%267.6K after10b5-1
Jun 9, 2023 (view filing)Jun 81 dayDeschatelets PascalChief Scientific OfficerSSale−12.0K$91.35−$1.10M−1.1%1.04M after10b5-1
Jun 6, 2023 (view filing)Jun 51 daySullivan Timothy EugeneChief Financial OfficerSSale−69.8K$88.80−$6.20M−47.3%77.7K after4 lots10b5-1
Jun 2, 2023 (view filing)Jun 11 dayLewis KarenChief People OfficerSSale−5.00K$86.00−$430.0K−10.8%41.5K after10b5-1
May 18, 2023 (view filing)May 171 dayMachiels AlecDirectorSSale−1.25K$88.66−$110.8K−0.5%267.6K after10b5-1
May 18, 2023 (view filing)May 162 daysFrancois CedricChief Executive OfficerSSale−30.0K$85.66−$2.57M−9.8%274.7K after6 lots
May 9, 2023 (view filing)May 81 dayDeschatelets PascalChief Scientific OfficerSSale−12.0K$92.39−$1.11M−1.1%1.03M after10b5-1
May 4, 2023 (view filing)May 31 dayTownsend Adam J.Chief Commercial OfficerSSale−5.00K$82.71−$413.6K−6.2%76.0K after10b5-1
Apr 20, 2023 (view filing)Apr 182 daysFrancois CedricChief Executive OfficerSSale−30.0K$82.02−$2.46M−4.5%637.6K after10b5-1
Apr 18, 2023 (view filing)Apr 171 dayMachiels AlecDirectorSSale−1.25K$81.05−$101.3K−0.5%267.6K after10b5-1
Apr 11, 2023 (view filing)Apr 101 dayDeschatelets PascalChief Scientific OfficerSSale−12.0K$78.21−$938.5K−1.2%1.03M after10b5-1
Apr 5, 2023 (view filing)Apr 32 daysDunlop A. SinclairDirectorSSale−500$74.05−$37.0K−0.4%131.3K after10b5-1
Apr 5, 2023 (view filing)Apr 32 daysLewis KarenChief People OfficerSSale−5.00K$75.00−$375.0K−10.8%41.4K after10b5-1
Apr 5, 2023 (view filing)Apr 32 daysTownsend Adam J.Chief Commercial OfficerSSale−5.00K$74.05−$370.3K−6.2%76.0K after10b5-1
Mar 23, 2023 (view filing)Mar 212 daysFrancois CedricChief Executive OfficerSSale−30.0K$62.74−$1.88M−2.6%1.14M after
Mar 21, 2023 (view filing)Mar 174 daysMachiels AlecDirectorSSale−1.25K$64.03−$80.0K−0.5%267.6K after
Mar 10, 2023 (view filing)Mar 82 daysDeschatelets PascalChief Scientific OfficerSSale−12.0K$63.79−$765.5K−1.2%1.02M after
Mar 7, 2023 (view filing)Mar 34 daysTownsend Adam J.Chief Commercial OfficerSSale−5.00K$63.84−$319.2K−6.2%76.0K after
Mar 2, 2023 (view filing)Mar 11 dayDunlop A. SinclairDirectorSSale−500$65.33−$32.7K−0.4%131.8K after
Feb 27, 2023 (view filing)Feb 234 daysEisele JeffreyChief Development OfficerSSale−1.65K$68.76−$113.2K−3.0%53.9K after
Feb 27, 2023 (view filing)Feb 234 daysLewis KarenChief People OfficerSSale−1.10K$68.76−$75.9K−2.6%41.4K after
Feb 21, 2023 (view filing)Feb 174 daysMachiels AlecDirectorSSale−1.25K$52.38−$65.5K−0.5%267.6K after
Feb 10, 2023 (view filing)Feb 82 daysDeschatelets PascalChief Scientific OfficerSSale−12.0K$54.45−$653.4K−1.2%1.01M after
Feb 6, 2023 (view filing)Feb 33 daysTownsend Adam J.Chief Commercial OfficerSSale−5.00K$55.85−$279.3K−6.9%67.9K after
Feb 2, 2023 (view filing)Feb 11 dayDunlop A. SinclairDirectorSSale−500$52.61−$26.3K−0.4%132.3K after
Jan 31, 2023 (view filing)Jan 301 dayEisele JeffreyChief Development OfficerSSale−883$52.76−$46.6K−1.9%46.5K after
Jan 31, 2023 (view filing)Jan 301 dayLewis KarenChief People OfficerSSale−883$52.76−$46.6K−2.4%36.5K after
Jan 25, 2023 (view filing)Jan 232 daysLewis KarenChief People OfficerSSale−2.96K$51.58−$152.4K−7.3%37.7K after
Jan 25, 2023 (view filing)Jan 232 daysEisele JeffreyChief Development OfficerSSale−4.48K$51.58−$231.0K−8.6%47.7K after
Jan 19, 2023 (view filing)Jan 172 daysMachiels AlecDirectorSSale−1.25K$52.42−$65.5K−0.5%267.6K after